Fast-track diagnostics releases CE-labelled Real-time PCR kit to detect Zaire Ebolavirus

NewsGuard 100/100 Score

Fast-track diagnostics, a global leader in the design, development and manufacture of infectious disease detection kits, has released a CE labelled Real-time PCR kit for the detection of the Zaire Ebolavirus – the strain responsible for the current outbreak in West Africa.

Fast-track diagnostics kits

The Ebolavirus assay is based on multiplex Real–time PCR so clinicians can deliver fast, accurate diagnoses leading to greater efficiency in the treatment of patients.

“Supporting infectious disease detection in the developing world has always been a priority for Fast-track diagnostics,” said Dr William Carman, CEO of Fast-track diagnostics. “We offer substantial discounts to these countries, as well as to anyone involved in relevant research projects. Therefore we are delighted to expand our extensive portfolio with this new addition.”

Fast-track diagnostics has one of the widest ranges available for single and multiplex kits for infectious diseases. Kits are available for over 100 different pathogens – including viruses, bacteria, fungi and parasites - many in multiplex syndrome panel format for commonly faced conditions including Respiratory Infections, Gastroenteritis, Meningitis and Infections of the Immunosuppressed. The entire range is compatible with many standard laboratory Real-time PCR cyclers and extraction methods.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production